Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that it attached Financial Results Conference Call Transcript of the Company for Q4 & FY22.
The above information is a part of company’s filings submitted to BSE.